Stockreport

Novartis' Q1 sales miss hints at industry's utilisation of M&A remedies [Yahoo! Finance]

 (RNAM) 
PDF The Swiss drugmaker reported a 12% drop in profits to $4.9bn compared with the same period in 2025. The profit tumble came alongside a decline in net sales, which reach [Read more]